The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20611iti2
The Journal of Experimental Medicine, Vol. 206, No. 11, 2304-
The Rockefeller University Press, 0022-1007 $30.00
© Maxmen
This Article
Right arrow Full Text (PDF, 1142K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Maxmen, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxmen, A.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

Revising the Th17 recipe


Figure 1
IL-6 alone induces IL-17 production in the absence of the Th1- and Th2-promoting transcription factors T-bet and STAT-6.

Contrary to popular belief, TGF-β doesn't directly induce Th17 cells. Here, Das et al. show that the cytokine merely paves the way for Th17s by blocking their antagonists.

The consensus among immunologists has been that TGF-β, along with IL-6, is a key ingredient in Th17 cell differentiation. But Das and colleagues find that in the absence of Th1 and Th2 cells, IL-6 alone can do the job. Naive CD4+ T cells from mice lacking the essential Th1 and Th2 transcription factors STAT-6 and T-bet produced copious IL-17 in response to stimulation with IL-6. And adding TFG-β to the mix had no effect.

The double-knockout mice developed severe EAE—an MS-like disease driven by Th17 cells. Their symptoms could be reversed by blocking IL-17 or IL-6, but not by blocking TGF-β. TGF-β inhibited Th1 and Th2 differentiation by downregulating the expression of the essential Th1 and Th2 transcription factors STAT-4 and GATA-3. With the competing subsets shut down, Th17s flourished.



Amy Maxmen

amaxmen{at}rockefeller.edu



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation
Jyoti Das, Guangwen Ren, Liying Zhang, Arthur I. Roberts, Xin Zhao, Alfred L.M. Bothwell, Luc Van Kaer, Yufang Shi, and Gobardhan Das
J. Exp. Med. 2009 206: 2407-2416. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 1142K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Maxmen, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxmen, A.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS